Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qiming Venture Partners is a leading China-based venture capital firm with global reach and an outstanding reputation for investing in early to growth-stage healthcare and technology startups. It manages over $9.5 billion in assets as of August 2024 and has backed numerous industry leaders across biotech/pharma/healthcare sectors both in China and internationally. Its U.S. arm focuses on transformative healthcare innovation with over $550 million raised since its founding in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qiming Venture Partners.